default author photo

Tatjana Schwarz

Charité - Universitätsmedizin Berlin - Institute of Virology

SCHOLARLY PAPERS

2

DOWNLOADS

168

TOTAL CITATIONS

1

Scholarly Papers (2)

1.

A Sars-Cov-2 Neutralizing Antibody Protects from Lung Pathology in a Covid-19 Hamster Model

Number of pages: 70 Posted: 26 Aug 2020
German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases (DZNE) Berlin, German Center for Neurodegenerative Diseases (DZNE), Charité - Universitätsmedizin Berlin - Institute of Virology, The Scripps Research Institute - Department of Integrative Structural and Computational Biology, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Wuhan University - Department of Cardiology, Department of Integrative Structural and Computational Biology, The Scripps Research Institute, Free University of Berlin (FUB) - Institut für Virologie, Institute of Integrative Neuroanatomy Berlin, Charité-Universitätsmedizin Berlin, Free University of Berlin (FUB) - Institut für Tierpathologie, German Center for Neurodegenerative Diseases (DZNE) Berlin, German Center for Neurodegenerative Diseases (DZNE) Berlin, German Center for Neurodegenerative Diseases (DZNE) Berlin, German Center for Neurodegenerative Diseases (DZNE) Berlin, German Center for Neurodegenerative Diseases (DZNE) Berlin, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Tierpathologie, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, Helmholtz Innovation Lab BaoBab (Brain antibody-omics and B-cell Lab), Institute of Integrative Neuroanatomy Berlin, Charité-Universitätsmedizin Berlin, Department of Rheumatology and Clinical Immunology, Charité-Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Department of Infectious Diseases and Respiratory Medicine, Charité –Universitätsmedizin Berlin, Department of Neurology and Experimental Neurology, Charité-Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin - Klinik und Hochschulambulanz für Neurologie, Neuroscience Research Center NWFZ, Institute of Virology, Charité-Universitätsmedizin Berlin, Institute of Virology, Charité-Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Department of Infectious Diseases and Respiratory Medicine, Charité-Universitätsmedizin Berlin, Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Free University of Berlin (FUB) - Institut für Virologie, Department of Integrative Structural and Computational Biology, The Scripps Research Institute and German Center for Neurodegenerative Diseases (DZNE)
Downloads 131 (558,171)
Citation 1

Abstract:

Loading...

COVID-19, SARS-COV-2, monoclonal antibody, neutralizing antibody, B cell, hamster

2.

Preclinial Safety and Efficacy of a Therapeutic Antibody That Targets SARS-CoV-2 at the Sotrovimab Face But is Escaped by Omicron

Number of pages: 49 Posted: 17 Aug 2022
German Center for Neurodegenerative Diseases (DZNE), German Center for Neurodegenerative Diseases (DZNE), Miltenyi Biotec B.V. & Co. KG, Berlin Institute of Health - Institute of Virology, German Center for Neurodegenerative Diseases (DZNE), Free University of Berlin (FUB) - Institut für Virologie, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, Miltenyi Biotec B.V. & Co. KG, German Center for Neurodegenerative Diseases (DZNE), Charité - Universitätsmedizin Berlin - Institute of Virology, Charité - Universitätsmedizin Berlin - Institute of Virology, Christian Albrechts-University of Kiel - Institute for Infection Medicine, Christian Albrechts-University of Kiel - Institute for Infection Medicine, IDEXX Laboratories, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, Free University of Berlin (FUB) - Institut für Virologie, German Center for Neurodegenerative Diseases (DZNE), Charité - Universitätsmedizin Berlin - Department of Infectious Diseases and Respiratory Medicine, Miltenyi Biotec B.V. & Co. KG, Charité - Universitätsmedizin Berlin - Institute of Virology and German Center for Neurodegenerative Diseases (DZNE)
Downloads 37 (1,222,651)

Abstract:

Loading...

COVID-19, SARS-CoV-2, therapeutic antibody, variant of concern, potency breadth, hamster model, human membrane protein library, human tissue cross-reactivity study, Omicron, N440K